A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Detection Panel and THC Metabolite, Umbilical Cord Tissue, Qualitative
MessageSendout - UCI (performed by ARUP: Test Code 3006371)
Reference: Order MISC through LifePoint: Drug Detection Panel and THC Metabolite, Umbilical Cord Tissue, Qualtative
Reference: Order MISC through LifePoint: Drug Detection Panel and THC Metabolite, Umbilical Cord Tissue, Qualtative
Test Code
LAB1238037
Alias/See Also
Drug Screens, Targeted, Serum or Plasma
Drugs of Abuse Panel
Meconium – Sreen with Reflex to Confirmation/Quantitation
Drugs of Abuse Panel
Meconium – Sreen with Reflex to Confirmation/Quantitation
CPT Codes
80307, 99001
Preferred Specimen
Umbilical Cord
Minimum Volume
8.0 inches
Other Acceptable Specimens
N/A
Instructions
Umbilical Cord (at least 8 inches, approximately the width of a sheet of paper). Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or water. Pat the cord dry.
Transport Container
Sterile container
Transport Temperature
Refrigerated
Specimen Stability
Ambient – 1 week
Refrigerated – 3 weeks
Frozen – 1 year
Refrigerated – 3 weeks
Frozen – 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens that exceed stated stability, unlabeled/mislabeled/mismatched specimens, specimens submitted in leaking containers, cords soaking in blood or other fluid. Formalin fixed. Tissue that is obviously decomposed.
Methodology
Qualitative Liquid Chromatography/Tandem Mass Spectrometry
FDA Status
Not approved
Setup Schedule
Sunday - Saturday
Report Available
1 – 4 days
Reference Range
Included with report
Clinical Significance
Detection of drugs in umbilical cord tissue is intended to reflect maternal drug use during approximately the last trimester of a full-term pregnancy. The pattern and frequency of drug(s) used by the mother cannot be determined by this test. A negative result does not exclude the possibility that a mother used drugs during pregnancy. Detection of drugs in umbilical cord tissue depends on extent of maternal drug use, as well as drug stability, unique characteristics of drug deposition in umbilical cord tissue, and the performance of any analytical method. Drugs administered during labor and delivery may be detected. Detectino of drugs in umbilical cord tissue does not insinuate impairment and may not affect outcomes for the infant. Interpretive questions should be directed to the laboratory.
Performing Laboratory
ARUP Laboratories, Salt Lake City, Utah